Breast cancer is a heterogeneous complex of diseases, a spectrum of many subtypes with
distinct biological features that lead to differences in response patterns to various treatment …

Gene expression profiling has reshaped our understanding of breast cancer by defining and
characterizing four main intrinsic molecular subtypes: human epidermal growth factor …

BACKGROUND: Pathologic complete response (pCR) is a surrogate end-point for prognosis
in neoadjuvant chemotherapy (NAC) for breast cancer. We aimed to report summary …

Background: Tumour-infiltrating lymphocytes (TILs) are known to be associated with
response to primary systemic therapy (PST) in breast cancer. This study was conducted to …

Background The pathological complete response (pCR) after neoadjuvant chemotherapy is
a surrogate marker for a favorable prognosis in breast cancer patients. Factors capable of …

Gene expression profiling has led to a new molecular classification of breast cancer
characterized by four intrinsic subtypes: basal-like, HER2-positive, luminal A, and luminal B …

Background We carried out a systematic review and meta-analysis to evaluate the predictive
roles of tumor infiltrating lymphocytes (TILs) in response to neoadjuvant chemotherapy …

Background Luminal breast cancer is a highly endocrine responsive disease. However, the
therapeutic benefit of chemotherapy (CT) in this population is not fully characterized. This …

With advances in science and technology, there are more innovations in the approach to
management of patients with breast cancer. Neoadjuvant chemotherapy that is designed to …

Background: The cancer stem cell (CSC) hypothesis has important clinical implications for
cancer therapeutics because of the proposed role of CSCs in chemoresistance. The aim of …